Eisai Machinery U.S.A. Inc. Acquires Parenteral Product Line from M.W. Technologies, Inc.
Share:
HACKENSACK, N.J., May 1 // -- Eisai Machinery U.S.A. Inc., a pharmaceutical machinery marketing and maintenance subsidiary of Tokyo-based Eisai Co., Ltd., today announces the acquisition of the parenteral machinery line from M.W. Technologies, Inc. The machines offer a solution for customers to conduct manual and semi-automatic inspection of parenteral - or intravenous - products, which is required by the U.S. Pharmacopeia and enforced by the U.S. Food and Drug Administration. Additionally, the acquisition serves to add manual and semi-automatic inspection machines to Eisai Machinery's existing product line of fully automatic inspection machines.
"Guided by a philosophy that defines our role as a human health care company - to give first thought to patients and their families and increase the benefits that health care provides - Eisai Machinery continues to expand its range of inspection equipment," says Michael de la Montaigne, President, Eisai Machinery U.S.A. Inc. "The acquisition of the manual and semi-automatic parenteral product line will further enhance our capabilities to provide quality service and machines to our customers."
The MIH-1 Free Standing Manual Inspection Station, MIH-dx Portable Manual Inspection Hood and MIH-dxs Semi-Automatic Manual Inspection Hood are ideal for small volume and sensitive product production runs, clinical labs, re-work of rejects from fully automated machines and as a validation tool for operators of this system and other in-line semi-automatic inspection systems. In addition, multiple inspection hoods up to 12 stations with transport conveyors are available for higher production levels.
The VIS-1000 inspection system provides a simple, effective method of inspecting pharmaceutical vials and ampoules. Both empty and filled products can be inspected with ease for a wide range of manufacturing flaws related to container and product integrity.
About Eisai Machinery U.S.A. Inc.
Eisai Machinery U.S.A. Inc. is a U.S. subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1981, Eisai Machinery manufactures pharmaceutical inspection systems known for their quality, efficiency and accuracy. Fully automated inspection machines by Eisai detect particulate matter and cosmetic defects in parenteral solutions. Other equipment distributed by Eisai Machinery includes leak-detection machines for ampoules and vials, capsule-weight inspection machines, and laser-based tablet analysis systems. Eisai's most advanced line of particulate and cosmetic machines include high-speed inspection for pre-filled syringes.
Source: Eisai Machinery U.S.A. Inc.
CONTACT: Cathy Pollini of Eisai, +1-201-746-2052
